-
18191-5A non-sedating antihistamine that selectively antagonizes the histamine H1 receptor with a Ki value of 10 nM and exhibits anti-inflammatory effects.
-
18191-50A non-sedating antihistamine that selectively antagonizes the histamine H1 receptor with a Ki value of 10 nM and exhibits anti-inflammatory effects.
-
18382-1An orally active PHD2 inhibitor (IC<sub>50</sub> = 3.9 µM) stabilizes HIF-&alpha and reversibly stimulate erythropoietin secretion at 100 µM in vitro increases hematocrit, red blood cell count, and hemoglobin levels at 50 mg/kg in
-
18382-10An orally active PHD2 inhibitor (IC<sub>50</sub> = 3.9 µM) stabilizes HIF-&alpha and reversibly stimulate erythropoietin secretion at 100 µM in vitro increases hematocrit, red blood cell count, and hemoglobin levels at 50 mg/kg in
-
18382-25An orally active PHD2 inhibitor (IC<sub>50</sub> = 3.9 µM) stabilizes HIF-&alpha and reversibly stimulate erythropoietin secretion at 100 µM in vitro increases hematocrit, red blood cell count, and hemoglobin levels at 50 mg/kg in
-
18382-5An orally active PHD2 inhibitor (IC<sub>50</sub> = 3.9 µM) stabilizes HIF-&alpha and reversibly stimulate erythropoietin secretion at 100 µM in vitro increases hematocrit, red blood cell count, and hemoglobin levels at 50 mg/kg in
-
15294-10An analog of 2-OG that has been developed as an inhibitor of HIF-PHs.
-
15294-25An analog of 2-OG that has been developed as an inhibitor of HIF-PHs.
-
15294-5An analog of 2-OG that has been developed as an inhibitor of HIF-PHs.
-
15294-50An analog of 2-OG that has been developed as an inhibitor of HIF-PHs.
-
A9814-5 mg
Thomas Scientific
FGFR inhibitor somewhat selective for FGFR2. It induces apoptosis and inhibits proliferation, invasion, and migration of breast cancer cells. (C08-0488-758)
Price: $211.27List Price: $234.75AZD-4547 is an inhibitor of FGFR that is somewhat selective for FGFR2 over FGFR1 and FGFR3 it exhibits anticancer chemotherapeutic activities. This compound is currently in clinical trials as a potential treatment for breast cancer. -
A9814-10 mg
Thomas Scientific
FGFR inhibitor somewhat selective for FGFR2. It induces apoptosis and inhibits proliferation, invasion, and migration of breast cancer cells. (C08-0488-988)
Price: $279.67List Price: $310.75AZD-4547 is an inhibitor of FGFR that is somewhat selective for FGFR2 over FGFR1 and FGFR3 it exhibits anticancer chemotherapeutic activities. This compound is currently in clinical trials as a potential treatment for breast cancer.